Lichtenstein GR, Travis S, Danese S, D'Haens G, Moro L, Jones R, et al. Budesonide MMX for the induction of remission of mild to moderate ulcerative colitis: a pooled safety analysis. J Crohns Colitis 2015;9(9):738-46. https://www.ncbi.nlm.nih.gov/pubmed/26094251
Salem G, Ding K, Sakuraba A, Cohen R. Role of topical tacrolimus in the management of proctitis, perianal manifestations in Crohn's disease, and chronic pouchitis: a systematic review. J Investig Med 2021. https://www.ncbi.nlm.nih.gov/pubmed/33622709
Sandborn WJ, Travis S, Moro L, Jones R, Gautille T, Bagin R, et al. Once-daily budesonide MMX(R) extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study. Gastroenterology 2012;143(5):1218-26 e1-2. https://www.ncbi.nlm.nih.gov/pubmed/22892337
Travis SP, Danese S, Kupcinskas L, Alexeeva O, D'Haens G, Gibson PR, et al. Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut 2014;63(3):433-41. https://www.ncbi.nlm.nih.gov/pubmed/23436336
